Aurora to Use Oracle's Informatics Muscle to Run More Efficient Clinical Trials; PGx in Long View

While Aurora's long-term plans include research using pharmacogenomic strategies, for the time being it will most likely use genomics for biomarker discovery work.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.